SCM
ZBH icon

Schnieders Capital Management’s Zimmer Biomet ZBH Stock Holding History

Schnieders Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,834
Closed -$232K – 153
2016
Q3 		$232K Hold
1,834
– – 0.13% 120
2016
Q2 		$214K Buy
+1,834
New +$208K 0.12% 131

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Schnieders Capital Management's ZBH Position: Q4 2016 in Review

Schnieders Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2016, closing a stake of 1,834 shares — an estimated $232K sold.

Schnieders Capital Management first reported a position in ZBH in Q2 2016 and held it in 2 quarters. The position peaked at $232K in Q3 2016. 812 funds tracked by Wall St. Rank hold ZBH as of Q4 2016.

  • Schnieders Capital Management reported no remaining Zimmer Biomet position as of Q4 2016 after selling out during the quarter.
  • Schnieders Capital Management sold 1,834 Zimmer Biomet shares in Q4 2016, an estimated $232K.
  • Schnieders Capital Management first reported a position in Zimmer Biomet in Q2 2016 and held it in 2 quarters.
  • Schnieders Capital Management's Zimmer Biomet position peaked at $232K in Q3 2016.
  • 812 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2016.

Based on Schnieders Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.